1114. Exploring bactericidal activity and emergence of resistance for carbapenem-resistant <i>Enterobacterales</i> (CRE) with and without <i>Klebsiella pneumoniae</i> carbapenemase (KPC) treated with optimized meropenem (MEM) and meropenem-vaborbactam (MEV) exposures
Open forum infectious diseases